Return to program book search

Session Information

FRM F110 - Systemic Immunosuppression in Dermatology: Pre-Treatment Work up, Dosing, Monitoring and Prevention of Adverse Effects

Open admission to eligible categories, no tuition or ticket


Date: Monday, March 24

CME Credits: 2.00

Location: Room 705/707

Time: 10:00 AM - 12:00 PM

Director: Nicole Fett, MD, FAAD - Handout

  • Joseph Merola, MD, MSc, FAAD
  • Junko Takeshita, MD, PhD, FAAD
  • David A. Wetter, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Complete the appropriate laboratory evaluation prior to providing systemic immunosuppressants
  • Provide the appropriate vaccines prior to starting systemic immunosuppressants
  • Describe the most common adverse effects of systemic immunosuppressants

Our session will cover special topics in systemic immunosuppressants. We will discuss the current recommendations on the prevention of glucocorticoid induced osteoporosis and dosing of bisphosphonates, pre-treatment vaccination recommendations, the REMs program for mycophenolate mofetil, the risks of infection and cancer with biologic and non-biologic agents, a therapeutic ladder for antimalarial use and the risk of retinal toxicity, and the use of systemic immunosuppressants in patients with chronic infections such as HIV and hepatitis B and C.


Monday, March 24
10:00 AMPart 1. Prevention of Glucocorticoid-Induced Osteoporosis. Part 2. Mycophenolate Mofetil: Pre-Treatment Vaccines, REMs, Dosing, Adverse Events / Dr. Fett
10:40 AMTNF-alpha Inhibitors: Use in Patients with HIV and Hepatitis B and C, Vaccine Use, Risk of Infections and Malignancy / Dr. Takeshita
11:10 AMAntimalarials: A Therapeutic Ladder, Risk of Retinal Toxicity and Retinal Screening Recommendations / Dr. Merola
11:30 AMMethotrexate and Azathioprine: Pre-Treatment Labs, Dosing, Monitoring and Concurrent Medications / Dr. Wetter